HMGB1 and prostate carcinoma: HMGB1 expression is typically higher in prostate cancer cells undergoing metastasis [37] and its expression exhibited a positive correlation with clinicopathological characteristics among prostate cancer patients concluding its prognostic relevance [24–33, 36, 37].